z-logo
open-access-imgOpen Access
Consensus report on controversial use of 5-alpha-reductase inhibitor in patients with benign prostatic hyperplasia under Taiwan National Health Insurance Regulations
Author(s) -
Te-Yen Chuang,
ChungCheng Wang,
PoCheng Chen,
Ming-Wei Kao
Publication year - 2019
Publication title -
urological science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 8
eISSN - 1879-5234
pISSN - 1879-5226
DOI - 10.4103/uros.uros_150_18
Subject(s) - medicine , family medicine , prostate cancer , dutasteride , gynecology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here